| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 08/01/2002 | WO2002059077A1 Aminoethanol derivatives |
| 08/01/2002 | WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 08/01/2002 | WO2002058532A2 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof |
| 08/01/2002 | WO2002040431A3 Compounds having fungicidal activity and processes to make and use same |
| 08/01/2002 | WO2002028841A3 Reagents for labeling biomolecules having aldehyde or ketone moieties |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | WO2002010160A3 Substituted heterocyclyl alkylamino-1,3,5-triazines |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | US20020103241 Such as N-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type II diabetes |
| 08/01/2002 | US20020103240 Process for resolution of 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole and compounds therefor |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103231 Such as 4-chloro-N-(4-(6-chloro-3a-hydroxy-8,8a-dihydro-3aH-indeno(1,2-d)thiazol-2 -yl)-phenyl)benzene-sulfonamide; for the prophylaxis or treatment of obesity |
| 08/01/2002 | US20020103201 Selective NPY (Y5) antagonists (triazines) |
| 08/01/2002 | US20020103199 Fused heteroaromatic glucokinase activators |
| 08/01/2002 | US20020103194 Secondary amine, imine, amidine, guanidine, or other nitrogen functional group compounds; for treatment or prevention of diseases in which treatment is mediated by muscarinic receptor agonism such as cognitive decline and Alzheimer's disease |
| 08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
| 08/01/2002 | US20020103190 Azo amino acids derivatives |
| 08/01/2002 | US20020103182 Improving elasticity or reducing wrinkles of a skin, for example; advanced glycosylation endproducts" or AGEs |
| 08/01/2002 | US20020103171 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 08/01/2002 | US20020103168 Fungicide phenylimine derivatives |
| 08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
| 08/01/2002 | DE10102084A1 Neue 1,4-Diamino-2-(thiazol-2-yl)-benzol-Derivate und diese Verbindungen enthaltende Färbemittel To new 1,4-diamino-2- (thiazol-2-yl) benzene derivatives and compositions containing these compounds colorant |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2435143A1 Halogen compounds having thrombopoietin receptor agonism |
| 08/01/2002 | CA2433819A1 Carboxamides as fungicides in agriculture |
| 08/01/2002 | CA2429353A1 Lfa-1 antagonist compounds |
| 07/31/2002 | EP1227084A1 Drug discharge pump inhibitors |
| 07/31/2002 | EP1225882A1 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 07/31/2002 | EP0934255B1 Production of pyridazine herbicides |
| 07/31/2002 | CN1361772A Substituted heteroaryloxyacetanilides and their use as herbicides |
| 07/31/2002 | CN1361768A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 07/31/2002 | CN1361759A 6-Hydroxy-2-naphthylcarbinol and process for the preparation thereof |
| 07/31/2002 | CN1360890A Use of active retiene derivative with negative hormone and/or antagonist |
| 07/30/2002 | US6426366 Pharmaceutical compositions comprising tyrphostins |
| 07/30/2002 | US6426355 Viricides; prevention production |
| 07/30/2002 | US6426354 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 07/30/2002 | US6426349 Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia |
| 07/25/2002 | WO2002057370A1 Dispers-reactive dyes containing acetoxymethylsulfone or vinylsulfone and their process |
| 07/25/2002 | WO2002057261A2 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 07/25/2002 | WO2002057252A2 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 07/25/2002 | WO2002057243A1 Novel 1,4-diamino-2-(thiazol-2-yl)benzene derivatives and dyes containing said compounds |
| 07/25/2002 | WO2002056827A2 Substituted felbamate derived compounds |
| 07/25/2002 | WO2002014320A3 Novel substituted diaryl azepine derivatives as integrin ligands |
| 07/25/2002 | WO2001090091A8 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/25/2002 | US20020099084 Pharmaceutically active compounds and methods of use |
| 07/25/2002 | US20020099074 Novel anilide compounds and drugs containing the same |
| 07/25/2002 | US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/25/2002 | CA2434296A1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 07/25/2002 | CA2427058A1 Substituted felbamate derived compounds |
| 07/24/2002 | EP1224316A2 13-alkyl epothilone derivatives |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP1224171A1 Beta disubstituted metalloprotease inhibitors |
| 07/24/2002 | EP1224165A1 Novel compounds |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | EP0946203B1 Tricyclic functional dyes for contrast enhancement in optical imaging |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360573A Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 07/24/2002 | CN1360570A Phenyl sulfamate derivs. |
| 07/24/2002 | CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates |
| 07/23/2002 | US6423730 Method to control termites |
| 07/23/2002 | US6423717 Nervous system disorders |
| 07/23/2002 | US6423709 Methods of using novel compounds as neuro-protective agents |
| 07/23/2002 | US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2002 | US6423699 Contraceptives |
| 07/18/2002 | WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 07/18/2002 | WO2002055491A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 07/18/2002 | WO2002055025A2 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
| 07/18/2002 | WO2002004409A3 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 07/18/2002 | WO2001094318A3 Method for synthesis of substituted azole libraries |
| 07/18/2002 | WO2001072685A3 Polyamine analogues as cytotoxic agents |
| 07/18/2002 | US20020095039 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 07/18/2002 | US20020094453 Metal coordination compound, luminescence device and display apparatus |
| 07/18/2002 | CA2434044A1 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha |
| 07/18/2002 | CA2433070A1 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 07/17/2002 | EP1222921A1 Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/17/2002 | EP1222195A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 07/17/2002 | EP1042327A4 A process for the reduction of oxiranyl epothilones to olefinic epothilones |
| 07/17/2002 | EP0946532B1 Preparation of thiazoles |
| 07/17/2002 | EP0939629A4 Thiol sulfonamide metalloprotease inhibitors |
| 07/17/2002 | CN1359390A Factor VII a inhibitors |
| 07/17/2002 | CN1359381A Thiazole-derivaties |
| 07/17/2002 | CN1359380A Diaminothiazoles and their use for inhibiting protein kinases |
| 07/17/2002 | CN1359379A Nematicidal trifluorobutenes |
| 07/17/2002 | CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 07/17/2002 | CN1358726A Tetrafluoalkylborate and use as conductive salt |
| 07/16/2002 | US6420566 Pharmaceutical compositions containing a 4, 5-dihydro-1, 3-thiazol-2-ylamine derivative, novel derivatives and preparation thereof |
| 07/16/2002 | US6420438 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/16/2002 | US6420426 Used to treat complications from diabetes mellitus |
| 07/16/2002 | US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 07/16/2002 | US6420390 Heteroarylpiperidines and their use as antipsychotics |
| 07/16/2002 | US6419857 Thiazolidines and use thereof for corrosion inhibition |
| 07/11/2002 | WO2002053547A1 Alkanoic acid derivatives, process for their production and use thereof |
| 07/11/2002 | WO2002053161A1 Method for treating fibrotic diseases or other indications |
| 07/11/2002 | WO2002053158A1 Method for treating glaucoma ib |
| 07/11/2002 | WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |